Back to Journals » Clinical Ophthalmology » Volume 4

Axial eye length measurements pre- and post- laser-assisted in situ keratomileusis using the IOL Master: a pilot study

Authors Chalkiadakis S, Amariotakis, Parikakis, Peponis V

Published 8 November 2010 Volume 2010:4 Pages 1267—1269


Review by Single anonymous peer review

Peer reviewer comments 3

Spyridon E Chalkiadakis, Georgios A Amariotakis, Efstratios A Parikakis, Vasileios G Peponis
Athens Eye Hospital, 2nd Eye Clinic, Athens, Greece

Purpose: A preliminary study in order to test the accuracy of the IOL Master in detecting axial eye length changes after laser-assisted in situ keratomileusis and to correlate the findings with the theoretical ablation depth.
Methods: Pre- and postoperative axial eye length measurements were performed in 10 consecutive eyes that underwent laser-assisted in situ keratomileusis with the Alcon Ladar Vision excimer laser to treat myopic refractive errors ranging from -2.50 to -8.00 diopters of spherical equivalent (mean: -5.23 ± 1.30 D).
Results: The preoperative axial eye length measurements ranged from 24.53 mm to 27.78 mm (mean: 25.80 ± 1.01 mm) and from 24.57 mm to 27.57 mm (mean: 25.68 ± 0.93 mm) 1 month after the operation. Preoperative and 1-month postoperative data showed a statistically significant difference (P <0.05).
Conclusions: The IOL Master showed a decrease in the axial eye length measurements that was bigger than the theoretical ablation depth and did not correlate well with it. Such data need to be confirmed by a larger cohort of patients.

Keywords: ablation, biometry, coherence, excimer, interferometry, keratomileusis, laser

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.